Pancreatic Cancer Research

ResearcherAbramson Cancer CenterActive in the last 2 years

John C. McVey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0668-5333; OpenAlex author ID A5061217689. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer. Co-author DOI 10.1038/s41598-026-35423-7↗
  2. TLR2 signaling regulates T cell exclusion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.195329↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gregory Lawrence Beatty · 2 shared papers, 2026 · strength 0.55
  2. Jacqueline Plesset · 1 shared paper, 2026 · strength 0.29
  3. Anna S. Thickens · 1 shared paper, 2026 · strength 0.29
  4. Meredith L. Stone · 1 shared paper, 2026 · strength 0.29
  5. Max Miller Wattenberg · 1 shared paper, 2026 · strength 0.26
  6. Ben Z. Stanger · 1 shared paper, 2026 · strength 0.26
  7. Robert H. Vonderheide · 1 shared paper, 2026 · strength 0.26
  8. Kim A. Reiss · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.